MISSION Rx Act

Hozzl · 2026-05-08T10:08:45Z

Explore the details of House Bill 8667 MISSION Rx Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

5/8/2026, 10:08 AM

Summary of Bill HR 8667

The "MISSION Rx Act" was introduced in the 119th Congress on May 7, 2026. The bill aims to address issues related to prescription drug access and affordability. Specific provisions or directives outlined in the bill include measures to enhance transparency in drug pricing, increase competition among pharmaceutical companies, and explore avenues to lower prescription medication costs for consumers. For detailed information and the full text of the bill, it can be accessed through the official PDF version available at the provided link.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 8667

Bill HR 8667 is currently in the status of Bill Introduced since May 7, 2026. Bill HR 8667 was introduced during Congress 119 and was introduced to the House on May 7, 2026. Bill HR 8667's most recent activity was Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of May 7, 2026

Bipartisan Support of Bill HR 8667

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8667

Primary Policy Focus

Alternate Title(s) of Bill HR 8667

MISSION Rx Act

Maximizing Individual Savings for Servicemembers In Obtaining Negotiated Rx Act

To amend titles 10 and 38, United States Code, to set the maximum cost-sharing amount paid by an eligible covered beneficiary under the TRICARE program and a veteran for such selected drug, as established under the Social Security Act, and the maximum price of a selected drug procured by Federal agencies, and for other purposes.